27,780 Alzheimer's and dementia studies in plain English, each scored out of 100.
A theory-guided non-experimental, descriptive, correlational design was used to evaluateentry and passage variables related to nursing home adjustment for individuals with dementia. 2 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
In 2026, the beginning of the 15th Five-Year Plan, the Central No. 1 Document emphasized the cultivation and expansion of county-level wealth-creating industries as the core approach to ensuring stable income growth for farmers. 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
Compared to direct estimation, the HB SAE model reduced the number of sub-districts with Relative Standard Errors (RSE) above 25% from 55 to 44, achieving lower Mean Squared Error (MSE) values and more stable estimates. 2 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
Here, new phenoxide derivatives of diisopropyl flourophosphate for reaction with Lewis basic sites on acetyl cholinesterase (AChE) were designed. 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
The Ukiyo Project is a collaborative initiative between the Faculty of Fine Arts at the Complutense University of Madrid (UCM) and the Faculty of Psychology at the University of Guanajuato (Mexico), aimed at promoting emotional well-being and mental health in the university environment through art. 2 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
Down syndrome (DS), caused by trisomy of chromosome 21, exhibits significant phenotypic variability, including intellectual disability, early-onset Alzheimer disease (AD), congenital heart defects (CHDs), haematological malignancies, and immune dysregulation. 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
Alzheimer disease is one of the causes of dementia that could make the patient lose their memories until they unable to do normal activities. 2 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
La enfermedad de Alzheimer (EA) fue descrita por primera vez en una mujer, Augusta D, cuyo caso reveló las características neuropatológicas clásicas de placas amiloides y ovillos neurofibrilares. 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
A doença de Alzheimer (DA) configura-se como a principal causa de demência em idosos, se tornando um dos maiores desafios da medicina moderna devido à sua alta prevalência e o impacto social associado. 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
Food is any substance, composed of carbohydrates, water, fats and proteins, which can be eaten or drunk by animals, including humans, for nutrition or pleasure. 2 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
The subscription based business model has significantly expanded beyond digital services, deeply penetrating the e-grocery and food delivery sectors. 3 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
This study examined how the COVID-19 pandemic altered the sociologic, individual, and biologic personhood of residents living with dementia in nursing homes, guided by Buron’s (2008) Personhood Model for Dementia Care (PMDC). 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
Breast cancer is a disease in which cells, originating from the breast epithelium, grow out of control and form tumors. 1 key finding →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
Crop area statistics in most of the states in India are provided based on complete enumeration or census approach. 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
The objective of a new report, ‘European Dementia Monitor 2017: comparing and benchmarking national dementia strategies and policies’, is to provide a benchmark of national dementia policies in order to compare the responses of European countries to the dementia challenge in different domains. 3 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
Public health surveillance of overweight prevalence is essential to assess the extent of the problem, identify regions and groups most affected and inform policy-making. 1 key finding →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
The results demonstrate similar poverty patterns as per county data findings on Kenya poverty report, 2022. 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
The World Health Organisation (WHO) predicts that, world-wide, depression will be the second largest source of burden of disease by 2020. 1 key finding →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
This article details the determinant bundle of store choice and the role of price as one of the major components in initial and ongoing store selection. 2 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
Glial activation and neuroinflammation play significant roles in apoptosis as well as in the development of cognitive and memory deficits. 3 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
OASIS-3 is a compilation of MRI and PET imaging and related clinical data for 1098 participants who were collected across several ongoing studies in the Washington University Knight Alzheimer Disease Research Center over the course of 15 years. 4 key findings →
Design: longitudinal study Participants: 1,098 Evidence: moderate
Full summary, score breakdown and related studies → Original source Free full text
A high incidence of fractures, particularly of the hip, represents an important problem in patients with Alzheimer disease (AD), who are prone to falls and have osteoporosis. 2 key findings →
Participants: 15 Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
Further research with DEMQOL is needed to confirm these findings in an independent sample, evaluate responsiveness, investigate the feasibility of use in specific subgroups and in economic evaluation, and develop population norms. 2 key findings →
Participants: 130 Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
Future studies are encouraged to adopt personalized internet-based supportive interventions to improve the health of family caregivers and their care recipients. 3 key findings →
Design: systematic review Evidence: high
Full summary, score breakdown and related studies → Original source Free full text
The results presented are sufficiently encouraging to recommend that the DEMQOL instruments be used alongside a generic measure such as the European Quality of Life-5 Dimensions (EQ-5D) in future studies of interventions in dementia as there was evidence that they can be more sensitive for patients at the milder end of disease and some limited evidence that the person with dementia measure may be able to reflect deterioration. 2 key findings →
Design: clinical trial Participants: 644 Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
Free full text links and the Full text may need a subscription label come from Unpaywall, Europe PMC and OpenAlex records of free copies, checked 10 Oct 2026. A study with neither is unknown, not paywalled.
This is alzhub's own score. It is not an official metric, not an impact factor, and no journal, publisher or ranking body endorses it. We built it so that a reader who is not a scientist can tell a landmark trial from a conference abstract without having to already know the difference. Every point comes from one of 20 components, all of them printed on the study itself, so you can disagree with our arithmetic rather than having to trust the total.
Journals are placed in ordered tiers, never given a numeric impact factor — we could not verify current impact factors from a source we control, and an invented one would be worse than none. Tier 1 is the top-tier general journals (NEJM, The Lancet, JAMA, Nature, Science, Nature Medicine); tier 2 is the leading specialty journals; tier 3 is every other peer-reviewed journal. A separate part scores how much the journal's own papers are cited, which tells the tier-3 journals apart.
Two rules we don't bend. First, we never fill in a missing value: if a record does not state a sample size or a design, that component scores zero, and if we simply have no data for a part, such as a citation count, that part is left out and the study is scored on the parts we could check. The study card says which. Second, anything that is not a peer-reviewed article is capped at 16/100 and carries a warning chip — so a conference abstract or a company press release can never outrank a peer-reviewed paper, no matter how good it looks.
We rank a rigorous null result — a good trial showing that something does not work — above an early positive finding. Someone deciding whether to buy a supplement is served by that, and the rigour is already counted by the design and journal components.
The score is computed from the published data alone and is reproducible: the same file always yields the same numbers.
See the whole rubric drawn out → — four charts covering all 27,780 studies: how the scores are spread and where the cap bites, which of the 20 components the library is strong and weak on, which subjects rest on stronger evidence, and what kinds of study each subject is actually built from.
This is a large sample of the Alzheimer's literature, not an exhaustive index of it. It holds 27,780 records, built mostly from automated pulls of Europe PMC (61.1% of the library) and OpenAlex (18.3%), plus smaller pulls from PubMed, Crossref and medRxiv. If a study, a drug, or a finding isn't here, that is not evidence it doesn't exist in the literature — it may simply not have been pulled in yet.
1,034 records (3.7% of the library) are not peer-reviewed — 962 of those are preprints posted before any journal review, and the rest are conference abstracts, regulatory notices and reports. Every study card on this page states its status plainly, and the score above is capped for anything that isn't a peer-reviewed article.
See the full, machine-readable breakdown of this library's coverage →